MALIGNANT SOLID TUMORS
Clinical trials for MALIGNANT SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT SOLID TUMORS trials appear
Sign up with your email to follow new studies for MALIGNANT SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug begins human testing
Disease control Not yet recruitingThis early-stage clinical trial is testing a new injectable drug called SHR-4298 in patients with advanced solid tumors that have returned or spread. The main goals are to find a safe dose and see if the drug can help control the cancer. The study will enroll about 200 adults who…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Early trial tests Two-Pronged attack on tough tumors
Disease control Not yet recruitingThis early-stage study is testing the safety of a new two-part treatment for advanced solid tumors. It combines a new drug, JCXH-211, injected directly into the tumor with an existing immunotherapy (anti-PD-1) given by IV. The goal is to see if this combination is safe and tolera…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Immorna Biotherapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for tough cancers: first patients to receive experimental drug
Disease control Not yet recruitingThis is the first time a new drug called TAK-505 is being given to people. The study aims to find a safe and effective dose for adults with advanced solid tumors—specifically certain stomach, lung, bowel, and head/neck cancers that have spread and are no longer responding to stan…
Matched conditions: MALIGNANT SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC